Loading...

Mark Savill, PhD

TitlePostdoctoral Scholar
SchoolUCSF School of Medicine
DepartmentPsychiatry
Address401 Parnassus Ave.
San Francisco CA 94143
Phone415-502-3622
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Savill M, D'Ambrosio J, Cannon TD, Loewy RL. Psychosis risk screening in different populations using the Prodromal Questionnaire: A systematic review. Early Interv Psychiatry. 2017 Aug 06. PMID: 28782283.
      View in: PubMed
    2. Farreny A, Savill M, Priebe S. Correspondence between negative symptoms and potential sources of secondary negative symptoms over time. Eur Arch Psychiatry Clin Neurosci. 2017 Jun 02. PMID: 28577223.
      View in: PubMed
    3. Savill M, Orfanos S, Bentall R, Reininghaus U, Wykes T, Priebe S. The impact of gender on treatment effectiveness of body psychotherapy for negative symptoms of schizophrenia: A secondary analysis of the NESS trial data. Psychiatry Res. 2017 Jan; 247:73-78. PMID: 27871030.
      View in: PubMed
    4. Priebe S, Savill M, Wykes T, Bentall R, Lauber C, Reininghaus U, McCrone P, Mosweu I, Bremner S, Eldridge S, Röhricht F. Clinical effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia: a multicentre randomised controlled trial. Health Technol Assess. 2016 Feb; 20(11):vii-xxiii, 1-100. PMID: 26869182; PMCID: PMC4782808.
    5. Savill M, Priebe S. Letter to the Editor: Concepts and methods when considering negative symptom course: a reply. Psychol Med. 2015 Aug; 45(11):2459-60. PMID: 25919939.
      View in: PubMed
    6. Savill M, Banks C, Khanom H, Priebe S. Do negative symptoms of schizophrenia change over time? A meta-analysis of longitudinal data. Psychol Med. 2015 Jun; 45(8):1613-27. PMID: 25425086.
      View in: PubMed
    7. Barnicot K, Savill M, Bhatti N, Priebe S. A pragmatic randomised controlled trial of dialectical behaviour therapy: effects on hospitalisation and post-treatment follow-up. Psychother Psychosom. 2014; 83(3):192-3. PMID: 24752222.
      View in: PubMed
    8. Priebe S, Savill M, Reininghaus U, Wykes T, Bentall R, Lauber C, McCrone P, Röhricht F, Eldridge S. Effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia--a multi-centre randomised controlled trial. BMC Psychiatry. 2013 Jan 14; 13:26. PMID: 23317474; PMCID: PMC3556155.
    9. Katsakou C, Marougka S, Barnicot K, Savill M, White H, Lockwood K, Priebe S. Recovery in Borderline Personality Disorder (BPD): a qualitative study of service users' perspectives. PLoS One. 2012; 7(5):e36517. PMID: 22615776; PMCID: PMC3355153.
    10. Savill M, Jankovic J, Katsakou C, Kallert T, Priebe S. Symptom levels and initial appraisal of hospital treatment in patients with schizophrenia. Psychiatry Res. 2012 Sep 30; 199(2):79-83. PMID: 22565214.
      View in: PubMed
    11. Barnicot K, Katsakou C, Bhatti N, Savill M, Fearns N, Priebe S. Factors predicting the outcome of psychotherapy for borderline personality disorder: a systematic review. Clin Psychol Rev. 2012 Jul; 32(5):400-12. PMID: 22681913.
      View in: PubMed
    Mark's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP